Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Costantino is a leading Italian manufacturer of peptones, protein hydrolysates, and extracts tailored for the pharmaceutical, biotechnological, and nutraceutical sectors. Established in 1922, the company has developed extensive expertise in enzymatic hydrolysis and purification technologies to produce high-performance growth factors for cell culture and fermentation. Their extensive catalog includes animal-derived, plant-based, and yeast-derived products that are critical for the production of vaccines, monoclonal antibodies, and recombinant proteins. Costantino operates from a sophisticated facility in Favria, Italy, which features dedicated production lines to prevent cross-contamination and ensure compliance with GMP and ISO standards. By providing consistent and scalable raw materials, the company serves as a vital partner for global biopharmaceutical companies and research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Costantino.